🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology · Approved programs

Oncology programs at Approved programs — ClinicalTrials.gov pipeline intelligence.

Programs
125

Quick answer

Oncology Approved programs programs: NovaPharmaNews indexes 125 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 2 of 3

  1. Fruquintinib

    Takeda

    Colorectal Cancer

    approved small molecule active

    1 trial

  2. GAVRETO ®(pralsetinib) capsules

    RIGEL PHARMACEUTICALS INC

    Patients with advanced or metastatic solid tumors

    approved small molecule active

    1 trial

  3. GEMCITABINE HYDROCHLORIDE, CISPLATIN, AVELUMAB, CISPLATIN, CISPLATIN, CISPLATIN, CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE

    Fondazione Telethon ETS

    metastatic or locally advanced urothelial cancer

    approved small molecule active

    1 trial

  4. Gadoterate meglumine

    Guerbet

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  5. Glivec 100 mg hard capsules, Tasigna 150 mg hard capsules

    Fondazione Telethon ETS

    Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

    approved small molecule active

    1 trial

  6. IMFINZI 50 mg/mL concentrate for solution for infusion., Lynparza 100 mg film-coated tablets, Lynparza 150 mg film-coated tablets

    AstraZeneca

    Advanced or recurrent endometrial cancer

    approved small molecule active

    1 trial

  7. INDOCYANINE GREEN

    The George Institute

    Patients with liver tumors that will undergo minimally invasive liver surgery

    approved small molecule active

    1 trial

  8. INDOCYANINE GREEN

    Disc Medicine

    cervical cancer stage I-IIA

    approved small molecule active

    1 trial

  9. Ibrutinib

    AbbVie Deutschland GmbH & Co. KG

    1. Follicular Lymphoma 2. Chronic Lymphocytic Leukemia 3. Waldenstrom macroglobulinemia 4. Multiple Myeloma 5. Marginal Zone Lymphoma 6. Diffuse Large B-Cell Lymphoma 7. Urothelial Carcinoma 8. Breast Cancer 9. Acute Myeloid Leukemia 10. Graft vs Host Disease 11. Mantle Cell Lymphoma

    approved small molecule active

    1 trial

  10. Ilaprazole

    Yang Xiaotian

    Gastric Cancer

    approved small molecule completed

    1 trial

  11. Intrathecal (injected into the spinal fluid) DepoCyt

    Pacira Ireland Limited

    Meningeal Neoplasms

    approved small molecule completed

    1 trial

  12. Iomeron 400 mgI/ml solution for injection

    The George Institute

    Thoracic neoplasm

    approved small molecule active

    1 trial

  13. Irinotecan liposomes combined with cisplatin/carboplatin

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    approved small molecule active

    1 trial

  14. Jejunostomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    approved other active

    1 trial

  15. KANG FU PEN

    The First People's Hospital of Lianyungang

    Cervical Cancer

    approved small molecule active

    1 trial

  16. LENVATINIB, NIVOLUMAB, CABOZANTINIB, LENVATINIB, NIVOLUMAB, AXITINIB, CABOZANTINIB, PEMBROLIZUMAB, IPILIMUMAB, AXITINIB, AXITINIB

    Fondazione Telethon ETS

    metastatic or locally advanced renal cell carcinoma

    approved small molecule active

    1 trial

  17. LETROZOLE, RIBOCICLIB, GOSERELIN ACETATE, LEE011, TAMOXIFEN

    Novartis Pharmaceuticals

    HR+, HER2- advanced or metastatic breast cancer

    approved small molecule active

    1 trial

  18. LORLATINIB

    Pfizer Australia Pty Ltd

    Lung cancer

    approved small molecule active

    1 trial

  19. Ledipasvir 90mg/Sofosbuvir 400 mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  20. Lutrate Depot Trimestral 22,5 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 150 mg film-coated tablets, Femara 2.5 mg Tablets, Arimidex® 1 mg film-coated tablets, Zoladex 10,8 mg implantat, Aromasil 25 mg comprimidos recubiertos, Verzenios 100 mg film-coated tablets, Zoladex 3,6 mg implantat, Kisqali 200 mg film-coated tablets, Lutrate Depot Mensual 3,75 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 50 mg film-coated tablets

    Ningbo Cancer Hospital

    Early Breast Cancer

    approved small molecule active

    1 trial

  21. METHADONE , Suboxone 2 mg/0.5 mg sublingual tablets

    Disc Medicine

    Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).

    approved small molecule active

    1 trial

  22. MORPHINE , EDOXABAN , ENZALUTAMIDE

    Disc Medicine

    Prostate cancer

    approved small molecule active

    1 trial

  23. MedPulser Electroporation with bleomycin

    INOVIO PHARMACEUTICALS, INC.

    Cancer

    approved other completed

    1 trial

  24. Medpulser electroporation with Bleomycin

    INOVIO PHARMACEUTICALS, INC.

    Head and Neck Cancer

    approved other terminated

    2 trials

  25. Mekinist, DRB436, DRB436, TMT212, TMT212, Mekinist 0.5 mg film-coated tablets, DRB436, Mekinist 2 mg film-coated tablets

    Novartis Pharmaceuticals

    Children and Adolescents with Cancers Harboring V600 mutation.

    approved small molecule active

    1 trial

  26. NIVOLUMAB

    Disc Medicine

    Melanoma, Renal cell carcinoma

    approved small molecule active

    1 trial

  27. Niraparib

    Takeda

    Epithelial Ovarian Cancer

    approved small molecule active

    1 trial

  28. ONTAK (denileukin difitox, DAB389IL-2)

    LIGAND PHARMACEUTICALS INC

    Lymphoma, T-Cell, Cutaneous

    approved small molecule completed

    1 trial

  29. OPDIVO 10 mg/mL concentrate for solution for infusion., CABOMETYX 20 mg film-coated tablets, CABOMETYX 40 mg film-coated tablets

    The George Institute

    Renal carcinoma

    approved small molecule active

    1 trial

  30. OROS hydromorphone

    Janssen Cilag International NV

    Cancer Pain

    approved small molecule completed

    1 trial

  31. OXALIPLATIN, CAPECITABINE

    Disc Medicine

    Locally advanced or metastatic gastro-intestinal carcinoma

    approved small molecule active

    1 trial

  32. Olutasidenib

    RIGEL PHARMACEUTICALS INC

    AML (Acute Myeloid Leukemia)

    approved small molecule active

    1 trial

  33. Oral prednisolone (30mg/day) for 28 days

    Hospital Authority, Hong Kong

    Esophageal Neoplasms

    approved small molecule active

    1 trial

  34. PEG-rhG-CSF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cervical Cancer

    approved small molecule active

    1 trial

  35. PEMBROLIZUMAB , NIVOLUMAB , IPILIMUMAB

    Disc Medicine

    Melanoma

    approved small molecule active

    1 trial

  36. Pegylated liposomal doxorubicin

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  37. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  38. Pluvicto 1 000 MBq/mL solution for injection/infusion

    Novartis Pharmaceuticals

    Prostate cancer

    approved small molecule active

    1 trial

  39. Pregabalin

    Pfizer

    Bone Neoplasms

    approved small molecule terminated

    1 trial

  40. RIBOCICLIB, Kisqali 200 mg film-coated tablets

    The George Institute

    Hormone receptor–positive (HRpos)/human epidermal growth factor receptor 2–negative (HER2neg) early breast cancer at risk of recurrence

    approved small molecule active

    1 trial

  41. Raltitrexed

    The First People's Hospital of Lianyungang

    Head and Neck Squamous Cell Carcinoma

    approved small molecule active

    1 trial

  42. Realgar-Indigo Naturalis Formulation Combined with Anlotinib

    The First People's Hospital of Lianyungang

    Platinum-resistant Ovarian Cancer (PROC)

    approved small molecule active

    1 trial

  43. Recombinant Human Adenovirus Type 5 injection

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    approved small molecule active

    1 trial

  44. Ribociclib

    Novartis Pharmaceuticals

    Metastatic Breast Cancer

    approved small molecule active

    1 trial

  45. S-1

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    approved small molecule active

    1 trial

  46. SELPERCATINIB, SELPERCATINIB

    Eli Lilly Co.

    Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration;

    approved small molecule active

    1 trial

  47. SIS-reinforced anastomosis

    Rocket Pharmaceuticals B.V.

    Rectal Cancer

    approved other active

    1 trial

  48. Sequential Icotinib Plus Chemotherapy

    Betta Pharmaceuticals Co.,

    EGFR Positive Non-small Cell Lung Cancer

    approved small molecule active

    1 trial

Frequently asked questions

How many oncology Approved programs programs exist?

125 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.